Gamot, an investment platform formed by private equity (PE) firm PAG along with PE funds CX Partners and Samara Capital has acquired a controlling stake in Chennai-based API manufacturer Anjan Drug.
— The Times of India
AZB & Partners advised PAG Asia Capital HK Limited led by a team of partners Ashwath Rau and Atreya Bhattacharya, senior associate Raina Upadhyay.
Desai & Diwanji advised bulk-drugs maker Anjan Drug led by a team of partner Siddarth Mody with senior associates Rahul Deodhar and Prerana Chaudhari.
Update 18 November: Quillon Partners represented CX Partners with a team led by partners Ankit Majmudar and Namrata Sinha with associate Stuti Khosla.
2020-08-01
Deal value: Confidential
This deal report is based on a firm's press release and may be only partially complete. Some firms or names of advisers may be therefore be missing.
Click here if you are working with a law firm that has not been credited for this deal, and we will update the report promptly.
Click to show comments
at your own risk
(alt+c)
By reading the comments you agree that they are the (often anonymous) personal views and opinions of readers, which may be biased and unreliable, and for which Legally India therefore has no liability. If you believe a comment is inappropriate, please click 'Report to LI' below the comment and we will review it as soon as practicable.
threads most popular
thread most upvoted
comment newest
first oldest
first
threads most popular
thread most upvoted
comment newest
first oldest
first